Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761866014 | Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3761867017 | Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Is a | Product containing lamivudine and nevirapine and stavudine (medicinal product) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has active ingredient | Stavudine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has active ingredient | Nevirapine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Is a | Lamivudine- and nevirapine- and stavudine-containing product in oral dose form | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Is a | Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Count of base of active ingredient | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has precise active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has basis of strength substance (attribute) | Lamivudine (substance) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has precise active ingredient | Stavudine (substance) | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has basis of strength substance (attribute) | Nevirapine (substance) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator value | 200 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has basis of strength substance (attribute) | Stavudine (substance) | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has presentation strength numerator value | 30 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Has precise active ingredient | Nevirapine (substance) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets